Next generation immunotherapeutic drugs for the treatment of severe infections and cancer
Composition of matter patent, that protects a wide family of chemical products and its uses as therapeutic drugs in cancer and infections caused by viral, fungal or bacterial pathogens.
Priority date March 24th 2023
Know more of this patent
Under evaluation at least till: 10th of May 2023
Rooteco Agriculture S.L. A Biofertilizers company based in ...
Oncoheroes Biosciences Inc. A biotech 100% focused on devel...